Results 201 to 210 of about 6,412 (238)
Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps. [PDF]
Orasan A+7 more
europepmc +1 more source
Cisplatin vestibulotoxicity: a current review. [PDF]
Fleihan T, Nader ME, Dickman JD.
europepmc +1 more source
The Utility of Contrast-Enhanced 3D-Real Inversion Recovery Magnetic Resonance Imaging in the Diagnosis of Endolymphatic Hydrops-A Retrospective Study of a Newly Implemented Clinical Service at a Tertiary Center. [PDF]
Abdulla J+6 more
europepmc +1 more source
Drug selection for inner ear therapy. [PDF]
Salt AN, Turner JG.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intratympanic gentamicin injections
Operative Techniques in Otolaryngology-Head and Neck Surgery, 2021Office-based intratympanic gentamicin injections are an important treatment modality for the management of refractory vestibular symptoms in patients suffering from Meniere's disease. Taking advantage of gentamicin's preferential vestibulotoxicity, chemical labyrinthectomy can be performed.
Brian M. Lin+2 more
openaire +2 more sources
Intratympanic Steroid Injection
Operative Techniques in Otolaryngology-Head and Neck Surgery, 2021Abstract Intratympanic steroid therapy is an important treatment modality for managing certain inner ear pathology. Indications for intratympanic steroid injections include sudden sensorineural hearing loss, Meniere's disease, autoimmune inner ear disease and acoustic trauma. In this article, we discuss the evidence supporting various indications for
Justin S. Golub+2 more
openaire +2 more sources
Primary Intratympanic Meningioma
Archives of Otolaryngology - Head and Neck Surgery, 1972A case of middle ear meningioma arising from the intratympanic course of the facial nerve, associated with neurofibromatosis and acoustic neuroma, is reported. Progressive unilateral facial nerve weakness in the absence of ear or central nervous system disease should alert the examining physician to the possibility of a tumor along the course of the ...
Edwin C. Everts, David D. DeWeese
openaire +3 more sources
Journal of Neurology, 2021
Intratympanic therapies, usually including glucocorticoid and gentamicin, are becoming worldwide used in clinical practice of Ménière's disease today. However, clinical efficacy and safety of these two therapies are still in controversial.Electronic searches in PubMed, CENTRAL, Web of Science, EMBASE, CINAHL, ClinicalTrials.gov and the European Union ...
Huawei Li, Weiming Hao, Huiqian Yu
openaire +3 more sources
Intratympanic therapies, usually including glucocorticoid and gentamicin, are becoming worldwide used in clinical practice of Ménière's disease today. However, clinical efficacy and safety of these two therapies are still in controversial.Electronic searches in PubMed, CENTRAL, Web of Science, EMBASE, CINAHL, ClinicalTrials.gov and the European Union ...
Huawei Li, Weiming Hao, Huiqian Yu
openaire +3 more sources
Intratympanic corticosteroids for Ménière’s disease
Cochrane Database of Systematic Reviews, 2021Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of intratympanic corticosteroids for Ménière's disease.
Webster, Katie E.+9 more
openaire +2 more sources